Peter Pytel to Disease Models, Animal
This is a "connection" page, showing publications Peter Pytel has written about Disease Models, Animal.
Connection Strength
0.307
-
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke. 2017 01; 48(1):187-194.
Score: 0.090
-
Pathogenesis of septic encephalopathy. Curr Opin Neurol. 2009 Jun; 22(3):283-7.
Score: 0.054
-
Muscle diseases: the muscular dystrophies. Annu Rev Pathol. 2007; 2:87-109.
Score: 0.045
-
Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome. Exp Neurol. 2015 Aug; 270:88-94.
Score: 0.019
-
Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity. Am J Pathol. 2014 Jan; 184(1):248-59.
Score: 0.018
-
Selective inhibition of caspases in skeletal muscle reverses the apoptotic synaptic degeneration in slow-channel myasthenic syndrome. Hum Mol Genet. 2014 Jan 01; 23(1):69-77.
Score: 0.018
-
Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas. Cancer Med. 2013 Aug; 2(4):457-67.
Score: 0.018
-
Selective knockdown of mutant SOD1 in Schwann cells ameliorates disease in G85R mutant SOD1 transgenic mice. Neurobiol Dis. 2012 Oct; 48(1):52-7.
Score: 0.017
-
Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy. Hum Mol Genet. 2011 Feb 15; 20(4):779-89.
Score: 0.015
-
Disruption of nesprin-1 produces an Emery Dreifuss muscular dystrophy-like phenotype in mice. Hum Mol Genet. 2009 Feb 15; 18(4):607-20.
Score: 0.013